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Abstract The harmful effects of smoking during pregnancy
are well known, but we lack prevalence data concerning this
subject in Austria. The aim ofz the present study was to deter-
mine the prevalence and any changes in the prevalence of
smoking during pregnancy in the last few years. The investi-
gation was conducted at a perinatal center in Vienna, Austria.
Further aims of the study were to evaluate maternal character-
istics associated with smoking and demonstrate the harmful
effects of smoking on neonatal outcome in this population.
Once inquired, self-reported smoking during pregnancy, ma-
ternal age, and neonatal data from 2007 to 2012 were evalu-
ated retrospectively. Of birth records, 11,142 were analyzed.
From 2007 to 2012, the prevalence of smoking declined sig-
nificantly from 19.1 to 15.6 %. The overall prevalence was
18.1 % and was highest (43.7 %) among young women
(<20 years). The risk of small for gestational age (SGA) was
significantly higher among newborns of smoking mothers.
Conclusion: The prevalence of smoking among pregnant
women has declined in Austria in the last few years but is still
quite high. Prevention programs should focus on young wom-
en, who are at highest risk in this regard.
What is Known:
• Smoking during pregnancy is known to exert harmful effects
What is New:
• Paucity of epidemiological data regarding this subject in Austria
• Significant decline of self-reported smoking during pregnancy from
2007 to 2012 in Vienna
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Although the harmful effects of smoking during pregnancy
are well known and have been investigated for more than
50 years, a significant number of women continue to smoke
during pregnancy. Thus, smoking still is a public health
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concern. In addition to causing the fetal tobacco syndrome [10],
it has been held responsible for the stagnation of infant
mortality in the last decade in Austria, along with alcohol
consumption and obesity in pregnant women [26].
Secondary complications due to maternal smoking lead to
higher hospital admission rates of infants from the postnatal
phase to the age of 5 years, which signifies higher health-
care-related costs [2, 16].
Smoking in the general population in Austria
With a smoking prevalence of 34 % in 2009, Austria ranks
among the top six countries in the European Union [23], as-
sumes the fourth highest rank in daily smoking (26 % of adult
women smoked on a daily basis in 2008) [17], and is among
the countries with the highest prevalence of teenage smoking.
The overall prevalence of teenage smoking is 25.4 %; among
girls, it ranges from 21.1 to 30.4 % depending on the age
group [9].
Smoking during pregnancy in Europe and Austria
A study comprising data from six European countries
(Belgium, Bulgaria, Germany, Greece, Ireland, and Portugal)
showed that the prevalence of smoking at the time of delivery
varied between 7 % (Bulgaria) and 52.5 % (Ireland), with a
mean smoking prevalence of 19.6 % [8]. Twenty-one percent
of pregnant women smoked in Germany [18], while 20–30 %
of pregnant women smoked in Austria in 2010 [10]. A study
conducted in Spain in 2013, addressing the effects of smoking
on fetal biometry, comprised 2478 women and revealed an
overall smoking prevalence of 32 % [4]. These data are con-
sistent with similar studies in Europe.
Harmful effects of smoking on the fetus
Smoking exerts harmful effects in every stage of pregnancy. It
is the most important preventable risk factor for an adverse
pregnancy outcome [1, 11]. Horak et al. [10] summarized the
known effects as the fetal tobacco syndrome. Cigarette smoke
contains toxins in quantities that affect placental and fetal cell
growth, proliferation, and differentiation and exert harmful
effects on the development of organ systems including the
cardiovascular, respiratory, and nervous system. Smoking re-
duces blood flow to the placenta and accumulates
carboxyhemoglobin in the fetus, both of which cause chronic
hypoxic stress for the fetus [1]. Placental metabolism is altered
in smoking women, and their placenta also revealed structural
differences as well as oxidative damage of the placental tissue
[21]. These effects might explain the higher risk of
miscarriage, fetal growth restriction, stillbirth, preterm birth,
and placenta praevia [11]. Fetal growth restriction results in
small for gestational age neonates. These neonates are bur-
dened with both short- and long-term health effects, including
higher risk for hyperglycemia during the neonatal period, fail-
ing to thrive during childhood, and obesity, early-onset type 2
diabetes, and arterial hypertension during adulthood [19].
Aims of the study
The aims of the study were the following:
1. To determine a statistically significant change, if any, in the
prevalence of smoking (yes/no) among pregnant women from
2007 to 2012.
2. To elucidate risk factors for maternal smoking, specifically
whether maternal age and parity influenced its prevalence.
Besides, neonatal outcome data were analyzed to confirm
the harmful effects of maternal smoking on newborns and
determine whether changes in prevalence would be reflected
in neonatal parameters.
Patients and Methods
The data for the study were collected at the obstetric depart-
ment of Sozialmedizinisches Zentrum (SMZ) Ost, a tertiary-
care medical center providing a wide spectrum of mother/
child health care. Data were collected from 2007 to 2012.
Every woman with a singleton pregnancy, who had delivered
her child after the 22nd week of gestation, was included in this
study. The women’s general and pregnancy-related medical
history was registered when they booked their delivery at
the hospital. Their current consumption of tobacco (yes/no;
if yes number of cigarettes/day) was registered in a personal
conversation by a midwife or a doctor and entered in an elec-
tronic data sheet. Womenwere classified into (0) non-smokers
or (1) smokers; and the numbers of cigarettes per day were
documented. Smoking behavior was registered once during
pregnancy. Maternal age was divided into the following cate-
gories: (0) younger than 20 years, (1) 20–25 years, (2) 26–
30 years, (3) 31–36 years, and (4) over 36 years. Neonatal
characteristics included birthweight and weight percentile.
The duration of pregnancy in weeks and days was also regis-
tered. The children were classified as preterm births (37 +
0 weeks or below) or small for gestational age (below the
10th percentile). Women who gave birth more than once in
the study period were treated as separate individuals in the
respective study year. Data obtained from a survey conducted
in 2002, comprising 576 women in the identical hospital
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setting, were used to compare the prevalence of smoking. All
data were pseudonymized.
Statistical analysis
Basic patient and neonatal data were collected at the initial
exploratory data analysis. Multiple logistic regressions were
used (a) to explore the association between the year of docu-
mentation and the occurrence of smoking, (b) to assess up-
ward and downward trends in the association between
smoking during pregnancy and maternal age, (c) to test for
the occurrence of small for gestational age children in con-
nection with maternal smoking, and (d) to test for the age
distribution throughout the study years. Linear regression
was used to assess the association between maternal age and
the number of cigarettes smoked per day. The χ2 test was used
to test for significance as to whether parity is associated with
smoking during pregnancy. The test was also used to deter-
mine the significance of relative risk and the number of ciga-
rettes causing preterm births and small for gestational age
newborns.
Kendall’s correlation coefficient was used to determine
whether smoking behavior changed between pregnancies.
The analysis was performed with IBM SPSS Statistics 21.
The relative risk and the number of cigarettes needed to cause
harm were calculated by using a modified Microsoft Excel
sheet by Dr. Georg Heinze available at http://www.
meduniwien.ac.at/user/georg.heinze/mb2. The level of
significance was set to p<0.05.
Results
Of 12,302 women who underwent their first antenatal inves-
tigation at SMZ Ost Hospital, 11,142 were included in the
study. Of the records, 1160 were excluded because of
twin/triplet pregnancies (n=823 single records), missing in-
formation in the charts, not completing the 22nd week of
gestation, or being lost to follow-up (n=337).
Characteristics of women and newborns
In the final dataset, 2022 (18.1 %) women had smoked
during the study years. The mean age of non-smokers
was 30.33 years (SD= 5.574) and that of smokers was
27.56 years (SD= 5.983). A total of 394 women were
below 20 years of age, of whom 222 (1.9 %) were
non-smokers and 172 (1.5 %) smokers. The largest
non-smoking group was 31–36 years old (34.5 %) and
the largest smoking group 20–25 years old (32.1 %). The
mean number of cigarettes smoked per day was 8.84
(SD=5.268), which corresponded to the category of 5–
10 cigarettes per day (43.9 %). Of the smokers, 36.2 %
smoked 1–5 cigarettes per day, and 19.9 % smoked more
than 10 cigarettes per day. Parity was rather evenly dis-
tributed among both groups, with slightly more primipa-
rous women in both groups. The mean duration of preg-
nancy in weeks was slightly higher in the non-smoking
group (38.85 % [SD= 2.384] vs. 38.69 % [SD= 2.47];
Table 1).
To determine changes in smoking behavior between preg-
nancies, women who had delivered more than one baby at the
hospital during the study period were viewed separately for
the purpose of the investigation. Of 1255 womenwho had two
babies at the study hospital, 212 smoked during one or both
pregnancies. Seventy-six (35.8 %) women increased their cig-
arette consumption, 43 (20.3 %) smoked the same number of
cigarettes, and the remaining women (n=93; 43.9 %) reduced
or quit smoking. Of 45 women who had three babies at the
hospital, 15 had smoked during one or more pregnancies.
Data concerning the newborns (Table 2) were divided ac-
cording to maternal smoking behavior. The infants of non-
smoking women had a higher mean birthweight in grams
(3352.7 [SD=615.57] vs. 3158 [SD=604.36]). The mean
weight percentile of infants born to smokers was 34.57
(SD = 25.49) and that of non-smokers was 43.94
(SD=26.91). Preterm birth rates were 8.3 % among non-
smoking women and 9.5 % among smoking women. The
incidence of small for gestational age children was slightly
higher among smokers than among non-smokers,
Risk factors for maternal smoking
The overall percentage of smokers during the study years was
18.1 %, increased from 19.1 % in 2007 to 19.3 % in 2008,
then remained constant at 19.3 % for 1 year and fell steadily
thereafter, reaching the lowest figure of 15.6 % in 2012. The
decline was significant in the logistic regression analysis with
an odds ratio (OR) of 0.952 (95 % confidence interval (CI)
0.926–0.980, p=0.00; Fig. 1).
The age distribution of pregnant women did not change
significantly throughout the study years (−0.22, 95 % CI
−0.46–1.52, p=0.42).
With regard to the age distribution, smokers accounted for
43.7 % of women younger than 20 years and 28.8 % of those
aged 20–25 years. The percentage of maternal smoking de-
creased with age; the lowest percentage of 13.2 % was ob-
served in women older than 36 years of age (Fig. 2). The
overall logistic regression function showed that the prevalence
of smoking fell steadily with increasing maternal age; the OR
was 0.917 (95 % CI 0.908–0.925, p=0.00).
Linear regression, which only took smokers (n=2022) into
account, revealed no linear relationship between maternal age
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and cigarette consumption. The model showed a R2 and ad-
justed R2 of 0.01, with a standard error of estimate of 5.266
(p=0.00). The weak R2 clearly indicates the absence of a
linear relationship between the two variables.
With regard to the number of births and smoking during
pregnancy, the χ2 test revealed a significant decline in
smoking with increasing numbers of births (31.359 [critical
value 18.307], df=10, p=0.001).
Table 1 Maternal characteristics
Characteristics of women Non-smokers Smokers
n (%) 9120 (81.9 %) 2022 (18.1 %)
Year of delivery
2007 1441 (80.9 %) 341 (19.1 %)
2008 1503 (80.7 %) 360 (19.3 %)
2009 1490 (80.7 %) 357 (19.3 %)
2010 1479 (81.5 %) 336 (18.5 %)
2011 1593 (82.8 %) 330 (17.2 %)
2012 1614 (84.4 %) 298 (15.6 %)
Age (mean, standard deviation) 30.33 ± 5.574 27.56 ± 5.983
Age categories Non-smokers Smokers
Younger than 20 years 222 (2.4 %a, 1.9 %c) 172 (8.5 %b, 1.5 %c)
20–25 years 1606 (17.6 %a, 14.4 %c) 649 (32.1 %b, 5.8 %c)
26–30 years 2837 (31.1 %a, 25.5 %c) 581 (28.7 %b, 5.2 %c)
31–36 years 3149 (34.5 %a, 28.5 %c) 448 (22.2 %b, 4.2 %c)
Over 36 years 1306 (14.3 %a, 11.7 %c) 172 (8.5 %b, 1.5 %c)
Number of cigarettes smoked per day
(mean, standard deviation)
0 8.84 ± 5.268
Number of cigarettes smoked per day Non-smokers Smokers
0 cigarette/day 9120 0 (81.9 %)
1–5 cigarettes/day 0 732 (36.2 %b, 6.6 %c)
5–10 cigarettes/day 0 887 (43.9 %b, 7.9 %c)
More than 10 cigarettes/day 0 403 (19.9 %b, 3.6 %c)
Parity Non-smokers Smokers
4329 (47.5 %a, 38.9 %c) 915 (45.3 %b, 8.2 %c)
4791 (52.5 %a, 42.9 %c) 1107 (54.7 %b, 9.9 %c)
Primiparous
Multiparous




Table 2 Characteristics of
newborns Neonatal outcome Non-smokers Smokers
Weight in grams (mean, standard deviation) 3352.7 ± 615.57 3158.39± 604.36
Weight percentile (mean, standard deviation) 43.94 ± 26.91 34.57 ± 25.49
Non-smokers Smokers
Preterm births (n, %) 758 (8.3 %a, 6.8 %c) 194 (9.5 %b, 1.7 %c)
Non-smokers Smokers
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Kendall’s correlation coefficient τb was used to assess
changes in smoking behavior between pregnancies. With a
correlation coefficient τb of 0.365 (p=0.00), no strong corre-
lation was registered between smoking during the first and the
second pregnancies. The analyses of three consecutive preg-
nancies revealed a moderately positive correlation (τb=0.611,
p=0.00) between the first and the second pregnancies but an
insignificant weak positive correlation between the second
and the third pregnancies (τb 0.394, p=0.106).
Neonatal outcome
Of 952 preterm infants, 194 (20.4 %) were born to
smoking mothers. In the risk analysis, the risk of bearing
preterm infants was just slightly higher among smokers
than among non-smoking women (9.6 vs. 8.3 %). The
relative risk was 1.15 (95 % CI 0.99–1.34), and the
number of cigarettes needed to cause harm was 12.9
(95 % CI −832.4–37.2). The χ2 test for 1 df was 3.49
(p= 0.0619).
Of 1424 small for gestational age (SGA) children, 27.2 %
(n=387) were born to smoking mothers. In the risk analysis,
the risk of bearing an SGA infant was 19.21 % (95 % CI
17.51–21) for smokers in contrast to 11.42 % for non-
smokers (95 % CI 10.78–12.10). Thus, the relative risk of a
smoker having a low-birthweight child increased by 1.68
(95 % CI 1.51–1.87), and the number of cigarettes needed to
cause harm was 12.9 (95 % CI 10.4–16.38). This becomes
significant in the χ2 test, with a value of 89.23 for 1 df
(p<0.0001).
The number of SGA children did not change statistically in
the study period. The odds ratio for the decline was 1.033 (95%
CI 0.966–1.041, p=0.887) among smokers and 1.033 (95%CI
0.968–1.104, p=0.328) among non-smokers.
Discussion
This study, conducted at a tertiary perinatal center in Vienna,
revealed that 18.1 % of pregnant women smoked during
Fig. 1 Change of maternal
smoking in the study years in
percent and absolute numbers
17% 12.4% 13.2% 43.7% 28.8% 
Fig. 2 Maternal age and smoking
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pregnancy; 19.1 % smoked in 2007, the highest prevalence of
19.3 % was registered in 2008/2009, and a steady decline was
observed thereafter, culminating in 15.6 % at the end of the
study period in 2012. A survey conducted in 2002, comprising
576 pregnant women at the same hospital, had shown that
21.5 % smoked during pregnancy (unpublished data). Thus,
the prevalence of smoking a few years before the commence-
ment of the present investigation appears to have been even
higher.
The most recent data in Austria—derived from 2010—
show that 20–30 % of pregnant women smoked [10].
However, the rates registered in the present study were con-
sistently lower than 20 %. Although maternal smoking has
been decreasing in other countries over the last few years [5,
25] and a steady decline was also noted in the present inves-
tigation, smoking rates remain high among young mothers
below 20 years of age (43.7 %) and those aged 20–25 years
(28.8 %). In our population, smoking rates among women
older than 36 years were below the overall prevalence.
The high prevalence of smoking among very young
pregnant women has been attributed to the high-risk behavior
and lack of responsibility at this age, which might have led to
pregnancy in the first place [7, 12]. This may well be true in
view of the fact that the smoking prevalence among pregnant
women below the age of 20 years, registered in the present
study, was approximately 20 % higher than that in the general
population.
The present study revealed no association between age and
the number of cigarettes smoked per day. The authors of pre-
vious studies mention that heavy smokers were largely older
mothers because of their prolonged exposure to tobacco be-
fore pregnancy and therefore greater addiction to nicotine [9,
15]; both of these studies comprised much larger sample sizes.
We registered a reduction in smoking rates during pregnan-
cy with the number of births. A positive correlation was noted
between smoking during the first and second pregnancies but
not between the second and third pregnancies. This might
indicate rising awareness of the harmful effects of smoking
on the part of the 15 women who experienced three pregnan-
cies during the study period. However, it may also have been
due to underreporting, secondary to social stigma experienced
in previous pregnancies.
Although the present study did indicate a higher risk of
preterm births in conjunction with smoking, the increased risk
was not statistically significant. This may have been due to the
sample size; the majority of studies addressing preterm births
and maternal smoking comprised much larger sample sizes
[3, 6, 13].
SGA is another birth outcome related to maternal smoking
during pregnancy [24]. The present study clearly showed a
higher risk of SGA among smoking mothers; the risk was
7.8 % higher and the number of cigarettes needed to cause
harm (in respect of giving birth to an SGA child) was 12.9.
Although maternal smoking clearly declined in the study
period (19.1 to 15.6 %), the decline in SGA children was not
statistically significant. This may have been due to the transfer
of high-risk pregnancies to the perinatal center and their im-
pact on birth outcome statistics. Another explanation could be
that smoking, in fact, did not decrease and the lower figures
indirectly reflected underreporting in the last few years. As
there have been no intensive campaigns denouncing smoking
in Austria and smoking is commonly regarded as a habit rather
than a health-damaging phenomenon, the underreporting the-
sis seems unlikely. Currently, we have no data concerning
changes in underreporting rates.
The strength of the present study is its large sample size; 11,
142 complete maternal records comprising self-reported
smoking behavior, maternal characteristics, and neonatal out-
come were studied. The most relevant limitation is that the
information on smoking status is based on self-reporting
alone. This may have led to underreporting because of the
stigma associated with smoking, especially during pregnancy.
Furthermore, underreporting may have been common in
women who had experienced previous pregnancies with un-
favorable outcomes and had been told that smoking cessation
may prevent problems in the forthcoming pregnancy.
Although a number of authors registered rather high discrep-
ancies in self-reported smoking status and cotinine measure-
ment [22], many of them agree that self-reporting is a reliable
means of determining smoking status during pregnancy [14].
In a Spanish study [4], the authors observed accurate self-
reporting (3.9%misreporting) and a very similar overall prev-
alence of smoking as in the present study (18.5 %).
Another limitation of the present study is that no socioeco-
nomic data were collected. However, given the fact that the
entire investigation was performed in a single region and the
same hospital setting, socioeconomic factors would probably
have not changed considerably during the study years. In con-
trast tomany countries, the absence of social security or access
to prenatal and perinatal care is no hindrance in Austria; 98 %
of the population have excellent social security coverage [20].
The high density of hospitals providing prenatal and perinatal
care and the Bmother-and-child card^ (Mutter-Kind-Pass) is
an established social security measure. This mother-and-child
card includes free but mandatory examinations during preg-
nancy and until the child’s second birthday. The first manda-
tory examination must be completed before the 16th gesta-
tional week. This checkup is taken quite seriously because
of its ensuing health benefits and child support payment.
A further limitation of the study is that the women’s
smoking status was only documented once during pregnancy.
For various reasons—such as the woman’s condition being
graded as a high-risk pregnancy some time later during her
pregnancy—this documentation was not performed at the
same time point in all women. The time of documentation
varied from the first trimester to the late third trimester.
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However, most of the information was obtained from early
pregnancy. Data concerning the cessation of smoking were
not registered. A meta-analysis by the CDC showed high var-
iability in cessation rates [25]. The present study did not ad-
dress smoking cessation, although cessation rates would prob-
ably have not altered the results substantially.
Conclusion
Once inquired, self-reported smoking during pregnancy de-
clined from 19.1 to 15.6 % in the study years. Urine cotinine
was not measured. Although the prevalence of smoking among
young women is still alarmingly high, the largest number of
smoking women is in the 22–31-year age category. Hence, both
age groups should be the focus of attention of anti-smoking
campaigns targeted at pregnant women. Primary educational
programs should focus on the youth in order to prevent addic-
tion at an early age. Further educational programs, including the
use of social media and online courses, should be implemented.
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